During the past decade, PRA Health Sciences conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 11 clinical trials were completed, i.e. on average, 17.5% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 11 clinical trials were completed. i.e. 31.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "PRA Health Sciences" #1 sponsor was "Bristol-Myers Squibb" with 21 trials, followed by "Eli Lilly and Company" with 9 trials sponsored, "Janssen Research & Development, LLC" with 8 trials sponsored, "Shire" with 3 trials sponsored and "Synlogic" with 3 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "PRA Health Sciences" #1 collaborator was "PRA Health Sciences" with 7 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "DF/Net Rearch" with 1 trials as a collaborator, "Denali Therapeutics Inc." with 1 trials as a collaborator and "ITT Research Institute" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "PRA Health Sciences" are "Healthy" (20 trials), "Healthy Participants" (12 trials), "Healthy Volunteers" (6 trials), "Alzheimer Disease" (4 trials) and "Pain" (3 trials). Many other conditions were trialed in "PRA Health Sciences" in a lesser frequency.

Most popular intervention types in "PRA Health Sciences" are "Drug" (76 trials), "Biological" (6 trials), "Other" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "BMS-986165" (5 trials), "Midazolam" (4 trials), "BMS-986036" (2 trials) and "Metformin" (2 trials). Other intervention names were less common.

The vast majority of trials in "PRA Health Sciences" are 73 trials for "All" genders, 6 trials for "Male" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "PRA Health Sciences". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 71 completed trials in PRA Health Sciences, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in PRA Health Sciences, 70 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

PRA Health Sciences has several departments that took part in Clinical trials: "PRA International Clinical Pharmacology Center (EDS US Clinic)" - 5 trials